Table 3 Echocardiographic and MRI functional measurements
From: 18F-florbetaben whole-body PET/MRI for evaluation of systemic amyloid deposition
Echo vs MRI parameters | Patient | ||||||||
|---|---|---|---|---|---|---|---|---|---|
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | |
LV ejection fraction (%) | |||||||||
Echo | 51.4 | 40.6 | 67.0 | 61.0 | 39.6 | 65 | 54.6 | 51.9 | 35.0 |
MRI | 63.0 | 38.0 | 50.0 | 60.0 | 35.0 | 59.0 | 44.0 | 52.0 | 26.0 |
End-diastolic volume (ml) | |||||||||
Echo | 77.4 | 47.7 | 66.1 | 58.0 | 139.9 | N/A | N/A | 122.7 | 119.5 |
MRI | 94.1 | 86.6 | 100.0 | 84.7 | 140.0 | 64.6 | 152.0 | 132.0 | 164.0 |
End-systolic volume (ml) | |||||||||
Echo | 37.6 | 28.3 | 21.8 | 22.6 | 84.5 | N/A | N/A | 59.1 | 77.3 |
MRI | 34.9 | 53.5 | 50.1 | 33.6 | 90.6 | 26.5 | 84.4 | 64.0 | 122.0 |
Time between echocardiogram and 18F-florbetaben PET/MRI | 3 d | 1 m | 3 m | 5 d | 2 m | 6 m | 1.5 m | 1 m | 6 m |